Diabetic peripheral neuropathic pain: Case studies

被引:3
作者
Belgrade, MJ
Cole, BE
McCarberg, BH
McLean, MJ
机构
[1] Amer Society Pain Educators, Montclair, NJ 07042 USA
[2] Univ Minnesota, Med Ctr, Pain & Palliat Care Ctr, Minneapolis, MN 55455 USA
[3] Kaiser Permanente, Chron Pain Management Program, San Diego, CA USA
[4] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA
关键词
D O I
10.1016/S0025-6196(11)61476-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Three case reports in this article Illustrate the diagnostic methods used and the treatment course encountered for many patients with diabetic peripheral neuropathic pain (DPNP). Each case addresses an aspect of DPNP: pain that appears to be refractory to initial therapy, DPNP occurring with other medical conditions, and nondiabetic neuropathy occurring in patients with diabetes mellitus. Together, these cases bring clarity to the confusing clinical experience for patients who have decreased sensation in combination with burning pain, and they apply the consensus guidelines for DPNP. Recently approved medications by the Food and Drug Administration for the treatment of DPNP offer hope for many patients whose pain was thought to be refractory to treatment.
引用
收藏
页码:S26 / S32
页数:7
相关论文
共 24 条
[1]   Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale [J].
Argoff, CE ;
Galer, BS ;
Jensen, MP ;
Oleka, N ;
Gammaitoni, AR .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 :S21-S28
[2]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[3]   Pharmacotherapy of painful diabetic neuropathy [J].
Richard Barbano ;
Stephanie Hart-Gouleau ;
Janet Pennella-Vaughan ;
Robert H. Dworkin .
Current Pain and Headache Reports, 2003, 7 (3) :169-177
[4]   Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy [J].
Barbano, RL ;
Herrmann, DN ;
Hart-Gouleau, S ;
Pennella-Vaughan, J ;
Lodewick, PA ;
Dworkin, RH .
ARCHIVES OF NEUROLOGY, 2004, 61 (06) :914-918
[5]  
Boulton A., 2005, Clinical Diabetes, V23, P9, DOI [10.2337/diaclin.23.1.9, DOI 10.2337/DIACLIN.23.1.9]
[6]   Diabetic somatic neuropathies [J].
Boulton, AJM ;
Malik, RA ;
Arezzo, JC ;
Sosenko, JM .
DIABETES CARE, 2004, 27 (06) :1458-1486
[7]   THE PREVALENCE BY STAGED SEVERITY OF VARIOUS TYPES OF DIABETIC NEUROPATHY, RETINOPATHY, AND NEPHROPATHY IN A POPULATION-BASED COHORT - THE ROCHESTER DIABETIC NEUROPATHY STUDY [J].
DYCK, PJ ;
KRATZ, KM ;
KARNES, JL ;
LITCHY, WJ ;
KLEIN, R ;
PACH, JM ;
WILSON, DM ;
OBRIEN, PC ;
MELTON, LJ .
NEUROLOGY, 1993, 43 (04) :817-824
[8]  
*E LILL CO, 2005, CYMB
[9]   Controlled-release oxycodone for pain in diabetic neuropathy - A randomized controlled trial [J].
Gimbel, JS ;
Richards, P ;
Portenoy, RK .
NEUROLOGY, 2003, 60 (06) :927-934
[10]   Duloxetine vs. placebo in patients with painful diabetic neuropathy [J].
Goldstein, DJ ;
Lu, YL ;
Detke, MJ ;
Lee, TC ;
Iyengar, S .
PAIN, 2005, 116 (1-2) :109-118